Year: 2025
Type: editorial
Abstract: belumosudil is tolerable and induces responses despite treatment failure as monotherapies.
Source: Blood
Author: R. Eric Davis
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4411235525